Logo image
Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion
Journal article   Peer reviewed

Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion

Gianfranco Di Renzo, Salvatore Amoroso, Maurizio Taglialatela, Lorella Canzoniero, Vincenzo Basile, Alessandro Fatatis and Lucio Annunziato
European journal of pharmacology, v 162(2), pp 371-373
1989
PMID: 2524399

Abstract

5-HT receptors Prolactin Quipazine
The present study was undertaken to characterize the type of serotonin (5-HT) receptors involved in the control of prolactin (PRL) secretion in male rats. d-Fenfluramine (10 mg/kg i.p.), a potent 5-HT releaser and quipazine, (20 mg/kg i.p.) a 5-HT agonist, caused a marked increase in serum PRL levels. Ritanserin (200 μg/kg i.p.), a specific antagonist of 5-HT 2 receptors, administered 1 h before the administration of d-fenfluramine or quipazine, completely prevented the PRL-releasing effect of these drugs. Furthermore, the administration of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH DPAT) (1.5, 3 and 6 mg/kg i.p.), a compound considered to be a prototypical 5-HT 1A agonist, failed to induce any change in serum PRL levels. The same lack of effect on PRL secretion was observed after the administration which has been shown to possess a higher selectivity for 5-HT 1B receptor subtypes than for 5-HT 1A subtypes. These results suggest that 5-HT receptors involved in the control of PRL secretion are of the 5-HT 2 type.

Metrics

5 Record Views
88 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Logo image